The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,021
Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells
Ludwig, N., Yerneni, S. S., Razzo, B. M., & Whiteside, T. L. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0358 · Cited by 191
Maione, F., Capano, S., Regano, D., Zentilin, L., Giacca, M., Casanovas, O., Bussolino, F., Serini, G., & Giraudo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58976 · Cited by 190
Regulation of tissue morphogenesis by endothelial cell-derived signals
Ramasamy, S. K., Kusumbe, A. P., & Adams, R. H. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.007 · Cited by 189
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Coleman, R. L., Gnant, M., Morgan, G. J., & Clézardin, P. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs263 · Cited by 189
Bai, L., Chen, P., Zhao, Y., Hang, R., Yao, X., Tang, B. H., Liu, C., Xiao, Y., & Hang, R. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121162 · Cited by 189
Palma, M. D., & Hanahan, D. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.011 · Cited by 188
MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth
Zhou, B., Ma, R., Si, W., Li, S., Yan, X., Tu, X., & Wang, Q. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.028 · Cited by 188
de Boer, R. A., Hulot, J., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J. K., Bertero, E., Coats, A. J. S., Čelutkienė, J., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2029 · Cited by 188
Integrating biological vasculature into a multi-organ-chip microsystem
Schimek, K. M. S., Busek, M., Brincker, S., Groth, B., Hoffmann, S., Lauster, R., Lindner, G., Lorenz, A., Menzel, U., Sonntag, F., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50217a · Cited by 187
Cell–cell junctional mechanotransduction in endothelial remodeling
Dorland, Y. L., & Huveneers, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2325-8 · Cited by 187
Ji, T., Zhao, Y., Ding, Y., & Nie, G. (2013) · Advanced Materials · doi:10.1002/adma.201300299 · Cited by 186
Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis
Parma, L., Baganha, F., Quax, P. H. A., & de Vries, M. R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.04.028 · Cited by 186
STEVENSON, W. C., Cheng, S.-F., Dastjerdi, M. H., Ferrari, G., & Dana, R. (2012) · The Ocular Surface · doi:10.1016/j.jtos.2012.01.005 · Cited by 185
Surace, L., Lysenko, V., Fontana, A. O., Cecconi, V., Janssen, H., Bicvic, A., Okoniewski, M. J., Pruschy, M. N., Dummer, R., Neefjes, J., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.009 · Cited by 185
Baker, B. M., Trappmann, B., Stapleton, S. C., Toro, E., & Chen, C. S. (2013) · Lab on a Chip · doi:10.1039/c3lc50493j · Cited by 185
STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer
Peña, C., Céspedes, M. V., Lindh, M. B., Kiflemariam, S., Mezheyeuski, A., Edqvist, P.-H. D., Hägglöf, C., Birgisson, H., Bojmar, L., Jirström, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1875 · Cited by 185
Acceptor engineering for NIR-II dyes with high photochemical and biomedical performance
Ji, A., Lou, H., Qu, C., Lu, W., Hao, Y., Li, J., Wu, Y., Chang, T., Chen, H., & Cheng, Z. (2022) · Nature Communications · doi:10.1038/s41467-022-31521-y · Cited by 183
Peng, Y., Wang, Y., Tang, N., Sun, D., Lan, Y., Yu, Z., Zhao, X., Feng, L., Zhang, B., Jin, L., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0926-9 · Cited by 183
Exploiting the bad eating habits of Ras-driven cancersPreprint
White, E. (2013) · Genes & Development · doi:10.1101/gad.228122.113 · Cited by 183
MicroRNA regulation in angiogenesis
Caporali, A., & Emanueli, C. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.006 · Cited by 182
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Alday-Parejo, B., Stupp, R., & Rüegg, C. (2019) · Cancers · doi:10.3390/cancers11070978 · Cited by 181
Moccia, F. D., Negri, S., Shekha, M. S., Faris, P. S., & Guerra, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163962 · Cited by 181
The hallmarks of cancer are also the hallmarks of wound healing
MacCarthy‐Morrogh, L., & Martin, P. B. (2020) · Science Signaling · doi:10.1126/scisignal.aay8690 · Cited by 181
Antonarakis, E. S., Heath, E. I., Smith, D. C., Rathkopf, D., Blackford, A. L., Danila, D. C., King, S., Frost, A., Ajiboye, A. S., Zhao, M., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-314 · Cited by 180
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest
Sick, É., Jeanne, A., Schneider, C., Dedieu, S., Takeda, K., & Martiny, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02099.x · Cited by 180
Abokyi, S., To, C. H., Lam, T. T., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7901270 · Cited by 180
Pathological angiogenesis and inflammation in tissues
Jeong, J.-H., Ojha, U., & Lee, Y. M. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01287-2 · Cited by 180
Lu-Emerson, C., Duda, D. G., Emblem, K. E., Taylor, J. W., Gerstner, E. R., Loeffler, J. S., Batchelor, T. T., & Jain, R. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9575 · Cited by 179
Self-citationMarx, U., Walles, H., Hoffmann, S., Lindner, G., Horland, R., Sonntag, F., Klotzbach, U., Sakharov, D. A., Tonevitsky, A., & Lauster, R. (2012) · Alternatives to Laboratory Animals · doi:10.1177/026119291204000504 · Cited by 179
Shih, T., Tien, Y.-J., Wen, C.-J., Yeh, T., Yu, M., Huang, C., Lee, Y., Yen, T., & Hsieh, S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.031 · Cited by 179
Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells
Herold, J. M., & Kalucka, J. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.624903 · Cited by 179
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer HeterogeneityPreprint
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 179
Self-citationTariq, M., Zhang, J., Liang, G., Ding, L., He, Q., & Yang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25895 · Cited by 178
Wiring the Vascular Network with Neural Cues: A CNS Perspective
Wälchli, T., Wacker, A., Frei, K., Regli, L., Schwab, M. E., Hoerstrup, S. P., Gerhardt, H., & Engelhardt, B. (2015) · Neuron · doi:10.1016/j.neuron.2015.06.038 · Cited by 178
Binet, F., & Sapieha, P. S. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.010 · Cited by 178
Shaping the brain vasculature in development and disease in the single-cell era
Wälchli, T., Bisschop, J., Carmeliet, P., Zadeh, G. M., Monnier, P. P., Bock, K. D., & Radovanovic, I. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00684-y · Cited by 178
Self-citationCerebral Edema in Traumatic Brain Injury
Winkler, E. A., Minter, D. J., Yue, J. K., & Manley, G. T. (2016) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2016.05.008 · Cited by 177
The glycolytic process in endothelial cells and its implications
Susan, W. S. L., & Shi, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00647-y · Cited by 177
Huang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176
Non-muscle myosin II in disease: mechanisms and therapeutic opportunities
Litwa, K., Horwitz, R., & Lamers, M. L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.022103 · Cited by 176
Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions
Qiu, Y., Tong, S., Zhang, L., Sakurai, Y., Myers, D. R., Lin, H., Lam, W. A., & Bao, G. (2017) · Nature Communications · doi:10.1038/ncomms15594 · Cited by 175
Rincón, M. Y., VandenDriessche, T., & Chuah, M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv205 · Cited by 174
Extracellular Vesicles in Skin Wound Healing
Narauskaitė, D., Kulkovienė, G., Rusteikaitė, J., Sampath, R., Rudaitytė, A., Stašytė, G., Calvente, M. I. A., & Jekabsone, A. (2021) · Pharmaceuticals · doi:10.3390/ph14080811 · Cited by 174
Zou, J., Fei, Q., Xiao, H., Wang, H., Liu, K., Liu, M., Zhang, H., Xiao, X., Wang, K., & Wang, N. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28395 · Cited by 173
Hou, W., Hu, S., Li, C., Ma, H., Wang, Q., Meng, G., Guo, T., & Zhang, J. (2019) · BioMed Research International · doi:10.1155/2019/2025636 · Cited by 173
Vascularization in tissue engineering: fundamentals and state-of-art
Yang, G., Mahadik, B. P., Choi, J. Y., & Fisher, J. P. (2019) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ab5637 · Cited by 173
Bone Morphogenetic Proteins in Vascular Homeostasis and DiseasePreprint
Goumans, M., Zwijsen, A., ten Dijke, P., & Bailly, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a031989 · Cited by 173
Stem cells and the vasculature
Bautch, V. L. (2011) · Nature Medicine · doi:10.1038/nm.2539 · Cited by 172
Endothelial Progenitor Cells for the Vascularization of Engineered Tissues
Peters, E. B. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0127 · Cited by 172
Metabolic Pathways Fueling the Endothelial Cell Drive
Li, X., Kumar, A., & Carmeliet, P. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114731 · Cited by 172
Self-citationTargeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
Li, Y., Zhao, L., & Li, X.-F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700407 · Cited by 172
Rolfe, B. E., Blakey, I., Squires, O., Peng, H., Boase, N. R. B., Alexander, C., Parsons, P. G., Boyle, G. M., Whittaker, A. K., & Thurecht, K. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja410351h · Cited by 171
Scholz, A., Harter, P. N., Cremer, S., Yalcin, B. H., Gurnik, S., Yamaji, M., Tacchio, M. D., Sommer, K., Baumgarten, P., Bähr, O., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505505 · Cited by 171
Therapeutic application of anti-angiogenic nanomaterials in cancers
Mukherjee, S., & Patra, C. R. (2016) · Nanoscale · doi:10.1039/c5nr07887c · Cited by 170
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
Chen, T. R., Wang, M., Chen, Y., & Liu, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03315-3 · Cited by 170
Molecular Genetic Analysis of Orf Virus: A Poxvirus That Has Adapted to Skin
Fleming, S. B., Wise, L. M., & Mercer, A. A. (2015) · Viruses · doi:10.3390/v7031505 · Cited by 169
EGFL7: a unique angiogenic signaling factor in vascular development and disease
Nichol, D., & Stuhlmann, H. (2011) · Blood · doi:10.1182/blood-2011-10-322446 · Cited by 169
ROS signaling and redox biology in endothelial cells
Panieri, E., & Santoro, M. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1928-9 · Cited by 168
Samuel, R., Daheron, L. M., Liao, S., Vardam, T. D., Kamoun, W. S., Batista, A., Buecker, C., Schäfer, R., Han, X., Au, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310675110 · Cited by 168
Self-citationThe Solid Mechanics of Cancer and Strategies for Improved Therapy
Stylianopoulos, T. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4034991 · Cited by 168
Vasculature-On-A-Chip for In Vitro Disease Models
Kim, S., Kim, W., Lim, S., & Jeon, J. S. (2017) · Bioengineering · doi:10.3390/bioengineering4010008 · Cited by 168
Liu, L., Liu, Y., Feng, C., Chang, J., Fu, R., Wu, T., Yu, F., Wang, X., Xia, L., Wu, C., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.007 · Cited by 168
Monocyte-endothelial cell interactions in vascular and tissue remodeling
Medrano-Bosch, M., Simón-Codina, B., Jiménez, W., Edelman, E. R., & Melgar‐Lesmes, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196033 · Cited by 168
Dieterich, L. C., Mellberg, S., Langenkamp, E., Zhang, L., Zieba, A., Salomäki, H., Teichert, M., Huang, H., Edqvist, P.-H. D., Kraus, T. F. J., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4072 · Cited by 167
Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer
Tamagnone, L. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.031 · Cited by 166
Elmasri, H., Ghelfi, E., Yu, D. C. W., Traphagen, S., Cernadas, M., Cao, H., Shi, G., Plutzky, J., Şahin, M., Hotamışlıgil, G. S., et al. (2012) · Angiogenesis · doi:10.1007/s10456-012-9274-0 · Cited by 166
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
Keskin, D., Kim, J., Cooke, V. G., Wu, C.-C., Sugimoto, H., Gu, C., De Palma, M., Kalluri, R., & LeBleu, V. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.035 · Cited by 165
The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses
Moens, S., Goveia, J., Stapor, P. C., Cantelmo, A. R., & Carmeliet, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.009 · Cited by 165
Self-citationDevelopments in preclinical cancer imaging: innovating the discovery of therapeutics
Conway, J. R. W., Carragher, N. O., & Timpson, P. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3724 · Cited by 165
In Vivo Analysis Reveals a Highly Stereotypic Morphogenetic Pathway of Vascular Anastomosis
Lenard, A., Ellertsdóttir, E., Herwig, L., Krudewig, A., Sauteur, L., Belting, H., & Affolter, M. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.010 · Cited by 165
Endothelial PGC-1α Mediates Vascular Dysfunction in Diabetes
Sawada, N., Jiang, A., Takizawa, F., Safdar, A., Manika, A., Tesmenitsky, Y., Kang, K.-T., Bischoff, J. E., Kalwa, H., Sartoretto, J. L., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.014 · Cited by 165
Molecular mechanisms of hypoxia in cancer
Challapalli, A., Carroll, L. S., & Aboagye, E. O. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0231-1 · Cited by 167
Ranchoux, B., Harvey, L. D., Ayon, R. J., Babicheva, A., Bonnet, S., Chan, S. Y., Yuan, J. X. ‐., & Pérez, V. D. J. (2017) · Pulmonary Circulation · doi:10.1177/2045893217752912 · Cited by 165
Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications
Ahmadi, M., & Rezaie, J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02426-5 · Cited by 165
Phenotypic diversity and metabolic specialization of renal endothelial cells
Dumas, S. J., Meta, E., Borri, M., Luo, Y., Li, X., Rabelink, T. J., & Carmeliet, P. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00411-9 · Cited by 165
Self-citationSun, Y., Chen, W., Torphy, R. J., Yao, S., Zhu, G., Lin, R., Lugano, R., Miller, E. N., Fujiwara, Y., Bian, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8922 · Cited by 165
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93182 · Cited by 164
Self-citationZhu, A. X., Finn, R. S., Mulcahy, M. F., Gurtler, J., Sun, W., Schwartz, J. D., Dalal, R. P., Joshi, A., Hozak, R. R., Xu, Y., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1442 · Cited by 164
Self-citationTumor cell vascular mimicry: Novel targeting opportunity in melanoma
Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., Chao, J.-T., Chien, D., & Chu, Y.-W. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.006 · Cited by 164
Mougel, A., Terme, M., & Tanchot, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00467 · Cited by 164
Li, H., Zhang, P., Luo, J., Hu, D., Huang, Y., Zhang, Z., Fu, Y. S., & Gong, T. (2019) · ACS Nano · doi:10.1021/acsnano.9b04166 · Cited by 164
VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2–dependent Ca 2+ signaling
Favia, A., Desideri, M., Gambara, G., D’Alessio, A., Ruas, M., Esposito, B. T., Bufalo, D. D., Parrington, J., Ziparo, E., Palombi, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406029111 · Cited by 163
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Viollet, B., & Bhat, M. K. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.63 · Cited by 162
Liu, T., Ma, W., Xu, H., Huang, M., Zhang, D., He, Z., Zhang, L., Brem, S. S., O’Rourke, D. M., Gong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05982-z · Cited by 162
Xu, Z., Zhu, C., Chen, C., Zong, Y., Feng, H., Liu, D., Feng, W., Zhao, J., & Lu, A. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1010-2 · Cited by 162
Extracellular Matrix (ECM) and Fibrosis in Adipose Tissue: Overview and Perspectives
Sun, K., Li, X., & Scherer, P. E. (2023) · Comprehensive physiology · doi:10.1002/cphy.c220020 · Cited by 162
A new era of cancer phototherapy: mechanisms and applications
Wang, Y., Ma, K., Kang, M., Yan, D., Niu, N., Yan, S., Sun, P., Zhang, L., Sun, L., Wang, D., et al. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00708e · Cited by 162
FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
Oellerich, M. F., & Potente, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246488 · Cited by 161
C1q as a unique player in angiogenesis with therapeutic implication in wound healing
Bossi, F., Tripodo, C., Rizzi, L., Bulla, R., Agostinis, C., Guarnotta, C., Munaut, C., Baldassarre, G., Papa, G., Zorzet, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311968111 · Cited by 161
An Inside View: VEGF Receptor Trafficking and Signaling
Simons, M. (2012) · Physiology · doi:10.1152/physiol.00016.2012 · Cited by 161
Zhao, Y., Hu, J., Sun, X., Yang, K., Yang, L., Kong, L., Zhang, B., Li, F., Li, C., Shi, B., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.402 · Cited by 161
da Motta, L. L., Ledaki, I., Purshouse, K. R., Haider, S. A., Bastiani, M. A. D., Baban, D., Morotti, M., Steers, G., Wigfield, S., Bridges, E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.184 · Cited by 160
Ghosh, A., Dasgupta, D., Ghosh, A. K., Roychoudhury, S., Kumar, D., Gorain, M., Butti, R., Datta, S., Agarwal, S. K., Gupta, S. C., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.123 · Cited by 161
Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
Huang, J., Yang, B., Peng, Y., Huang, J., Wong, S. H. D., Bian, L., Zhu, K., Shuai, X., & Han, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202011171 · Cited by 160
Katoh, M. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1444 · Cited by 159
Angiogenesis and liver fibrosis
Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 159
Patel, A. B., Sabbineni, H., Clarke, A., & Somanath, P. R. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.05.036 · Cited by 159
Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Elebiyo, T., Rotimi, D. E., Evbuomwan, I. O., Maimako, R. F., Iyobhebhe, M. E., Ojo, O. A., Oluba, O. M., & Adeyemı, O. S. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100620 · Cited by 159
Angiogenesis and hypoxia in the kidney
Tanaka, T., & Nangaku, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.35 · Cited by 158
CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development
Tu, T., Zhang, C., Yan, H., Luo, Y., Kong, R., Wen, P., Ye, Z., Chen, J., Feng, J., Liu, F., et al. (2015) · Cell Research · doi:10.1038/cr.2015.15 · Cited by 158
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
